Skip to main content

Chronic administration of a partial agonist at strychnine-insensitive glycine receptors: a novel experimental approach to the treatment of ischemias

  • Conference paper
Advances in Research on Neurodegeneration
  • 104 Accesses

Summary

During the past decade, converging lines of evidence have linked the abnormal release or leak of excitatory amino acids to the neurodegeneration associated with a wide range of pathologies including cerebral ischemias, Huntington’s disease, and AIDS dementia (Coyle and Robinson, 1987; Lipton, 1994; Meldrum, 1994). Pharmacological studies indicate that activation of both ionotropic and metabotropic glutamate receptors can substantially contribute to excitotoxic cell damage (Choi, 1992; Pizzi et al, 1993; Sheardown et al., 1993; Xue et al., 1994). Based on these findings, therapeutic strategies based on blunting or blocking glutamatergic transmission may be useful in treating a variety of neurodegenerative disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bakshi R, Faden AI (1990) Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res 507: 1–5

    Article  PubMed  CAS  Google Scholar 

  • Beaughard M, Michelin M, Massingham R (1990) Effects of the putative glycine antagonist HA-966 on the neurological and histological changes induced by transient global ischemia in rats and gerbils. In: Krieglstein J, Oberpichler H (eds) Pharmacology of cerebral ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 275–280

    Google Scholar 

  • Boje K (1994) In vitro and in vivo studies with glycine partial agonists: a novel strategy for preventing NMDA receptor—mediated tissue damage. In: Palfreyman MG, Reynolds IJ, Skolnick P (eds) Direct and allosteric control of glutamate receptors. CRC Press, Boca Raton, pp 119–126

    Google Scholar 

  • Boje KM, Wong G, Skolnick P (1993) Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar cell cultures. Brain Res 603: 207–214

    Article  PubMed  CAS  Google Scholar 

  • Choi DW (1992) Excitotoxic cell death. J Neurobiol 23: 1261–1276

    Article  PubMed  CAS  Google Scholar 

  • Evoniuk GE, Hertzman RP, Skolnick P (1991) A rapid method for evaluating the behavioral effects of dissociative anesthetics in mice. Psychopharmacol 105: 125–128

    Article  CAS  Google Scholar 

  • Fossom LH, Von Lubitz DKJE, Lin RC-S, Skolnick P (1995a) Neuroprotective actions of 1-aminocyclopropanecarboxylic acid, a partial agonist at strychnine-insensitive glycine sites. Neurol Res 17: 265–269

    PubMed  CAS  Google Scholar 

  • Fossom LH, Basile AS, Skolnick P (1995b) Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters NMDA receptor function and subunit composition. Mol Pharmacol 48: 981–987

    PubMed  CAS  Google Scholar 

  • Hartley DM, Moyner H, Colamarino SA, Choi DW (1990) 7-Chlorokynurenate blocks NMDA receptor mediated neurotoxity in murine cortical culture. Eur J Neurosci 2: 291–295

    Article  PubMed  Google Scholar 

  • Isaac L, van Zandt O’Malley T, Ristic H, Stewart P (1990) MK-801 blocks dynorphin A (l–13)-induced loss of the tail-flick reflex in the rat. Brain Res 531: 83–87

    Article  PubMed  CAS  Google Scholar 

  • Kleckner NW, Dingledine R (1988) Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241: 835–837

    Article  PubMed  CAS  Google Scholar 

  • Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M (1992) Molecular diversity of the NMDA receptor channel. Nature 358: 36–41

    Article  PubMed  CAS  Google Scholar 

  • Laurie DJ, Seeburg PH (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur J Pharmacol 268: 335–345

    Article  PubMed  CAS  Google Scholar 

  • Layer RT, Bland LR, Skolnick P (1993) MK-801, but not drugs acting at strychnine-insensitive glycine receptors, attenuate methamphetamine nigrostriatal toxicity. Brain Res 625: 38–44

    Article  PubMed  CAS  Google Scholar 

  • Lipton SA (1994) Ca2+, N-methyl-D-aspartate receptors, and AlDS-related neuronal injury. Int Rev Neurobiol 36: 1–27

    Article  PubMed  CAS  Google Scholar 

  • Lombardi G, Moroni F, Moroni F (1994) Glutamate receptor antagonists protect against ischemia-induced retinal damage. Eur J Pharmacol 271: 489–495

    Article  PubMed  CAS  Google Scholar 

  • Long JB, Skolnick P (1994) 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur J Pharmacol 261: 295–301

    Article  PubMed  CAS  Google Scholar 

  • Long JB, Rigamonti DD, Oleshansky MA, Wingfield CP, Martinez-Arizala A (1994) Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J Pharmacol Exp Ther 269: 358–366

    PubMed  CAS  Google Scholar 

  • Marvizon JC, Lewin AH, Skolnick P (1989) 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex. J Neurochem 52: 992–994

    Article  PubMed  CAS  Google Scholar 

  • Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, Yamazaki M, Kumanishi T, Arakawa M, Sakimura K, Mishina M (1992) Functional characterization of a hete—romeric NMDA receptor channel expressed from cloned cDNAs. Nature 357: 70–74

    Article  PubMed  CAS  Google Scholar 

  • Meldrum B (1994) Neuroprotection by NMDA and non-NMDA glutamate antagonists. In: Palfreyman MG, Reynolds IJ, Skolnick P (eds) Direct and allosteric control of glutamate receptors. CRC Press, Boca Raton, pp 127–138

    Google Scholar 

  • Miller R, La Grone J, Skolnick P, Boje KM (1992) High-performance liquid chromato¬graphic assay for 1-aminocyclopropanecarboxylic acid from plasma and brain. J Chromatogr 578: 103–108

    Article  PubMed  CAS  Google Scholar 

  • Muir KW, Grosset DG, Gamzu E, Lees KR (1994) Pharmacological effects of the noncompetitive NMD A antagonist CNS 1102 in normal volunteers. Br J Clin Pharmacol 38: 33–38

    PubMed  CAS  Google Scholar 

  • Patel J, Zinkand WC, Thompson C, Keith R, Salama A (1990) Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J Neurochem 54: 849–854

    Article  PubMed  CAS  Google Scholar 

  • Pizzi M, Fallacara C, Arrighi V, Memo M, Spano PF (1993) Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J Neurochem 61: 683–689

    Article  PubMed  CAS  Google Scholar 

  • Robinson MB, Coyle JT (1987) Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J 1: 446–455

    PubMed  CAS  Google Scholar 

  • Sheardown MJ, Suzdak PD, Nordholm L (1993) AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur J Pharmacol 236: 347–353

    Article  PubMed  CAS  Google Scholar 

  • Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY (1994) Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144–147

    Article  PubMed  CAS  Google Scholar 

  • Skolnick P, Marvizon J, Jackson B, Monn J, Rice K, Lewin A (1989) Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropane-carboxylates. Life Sei 45: 1647–1655

    Article  CAS  Google Scholar 

  • Skolnick P, Miller R, Young A, Boje K, Trullas R (1992) Chronic treatment with 1-aminocyclopropane-carboxylic acid desensitizes behavioral responses to agents acting at the N-methyl-D-aspartate receptor complex. Psychopharmacol 107: 489–496

    Article  CAS  Google Scholar 

  • Sonsalla PK, Riordan DE, Heikkila RE (1991) Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256: 506–512

    PubMed  CAS  Google Scholar 

  • Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan DS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16: 165–174

    Article  PubMed  CAS  Google Scholar 

  • von Lubitz D, Lin R, McKenzie R, Devlin T, McCabe RT, Skolnick P (1992) A novel treatment of global cerebral ischemia with a glycine partial agonist. Eur J Pharmacol 219: 153–158

    Article  Google Scholar 

  • Wafford KA, Bain CJ, Le Bourdelles B, Whiting PJ, Kemp JA (1993) Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. Neuro Report 4: 1347–1349

    CAS  Google Scholar 

  • Watson G, Lanthorn TH (1990) Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor associated glycine site. Neuropharmacol 29: 727–730

    Article  CAS  Google Scholar 

  • Williams K (1993) Ifenprodil discriminates subtypes of N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44: 851–859

    PubMed  CAS  Google Scholar 

  • Witkin J, Steele T (1992) Effects of strychnine-insensitive glycine receptor ligands on discriminative stimulus effects of N-methyl-D-aspartate (NMDA) channel antago¬nists. Abstr Soc Neurosci 18: 447, #192.16

    Google Scholar 

  • Xue D, Huang Z-G, Barnes K, Lesiuk HJ, Smith KE, Buchan AM (1994) Delayed treatment with AMPA, but not NMDA, antagonists reduce neocortical infarction. J Cereb Blood Flow Metab 14: 251–261

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag/Wien

About this paper

Cite this paper

Fossom, L.H., Skolnick, P. (1997). Chronic administration of a partial agonist at strychnine-insensitive glycine receptors: a novel experimental approach to the treatment of ischemias. In: Mizuno, Y., Youdim, M.B.H., Calne, D.B., Horowski, R., Poewe, W., Riederer, P. (eds) Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6844-8_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6844-8_24

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82934-9

  • Online ISBN: 978-3-7091-6844-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics